{"downloaded": true, "htmlmade": false, "full": {"id": "29784643", "source": "MED", "pmid": "29784643", "pmcid": "PMC6034645", "fullTextIdList": {"fullTextId": "PMC6034645"}, "doi": "10.1182/blood-2018-04-842880", "title": "The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.", "authorString": "Rasche L, Angtuaco EJ, Alpe TL, Gershner GH, McDonald JE, Samant RS, Kumar M, Van Hemert R, Epstein J, Deshpande S, Tytarenko R, Yaccoby S, Hillengass J, Thanendrarajan S, Schinke C, van Rhee F, Zangari M, Walker BA, Barlogie B, Morgan GJ, Davies FE, Weinhold N.", "authorList": {"author": [{"fullName": "Rasche L", "firstName": "Leo", "lastName": "Rasche", "initials": "L", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Angtuaco EJ", "firstName": "Edgardo J", "lastName": "Angtuaco", "initials": "EJ", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Radiology Department, University of Arkansas for Medical Sciences, Little Rock, AR; and."}}}, {"fullName": "Alpe TL", "firstName": "Terri L", "lastName": "Alpe", "initials": "TL", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Gershner GH", "firstName": "Grant H", "lastName": "Gershner", "initials": "GH", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "McDonald JE", "firstName": "James E", "lastName": "McDonald", "initials": "JE", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Radiology Department, University of Arkansas for Medical Sciences, Little Rock, AR; and."}}}, {"fullName": "Samant RS", "firstName": "Rohan S", "lastName": "Samant", "initials": "RS", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Radiology Department, University of Arkansas for Medical Sciences, Little Rock, AR; and."}}}, {"fullName": "Kumar M", "firstName": "Manoj", "lastName": "Kumar", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Radiology Department, University of Arkansas for Medical Sciences, Little Rock, AR; and."}}}, {"fullName": "Van Hemert R", "firstName": "Rudy", "lastName": "Van Hemert", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Radiology Department, University of Arkansas for Medical Sciences, Little Rock, AR; and."}}}, {"fullName": "Epstein J", "firstName": "Joshua", "lastName": "Epstein", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Deshpande S", "firstName": "Shayu", "lastName": "Deshpande", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Tytarenko R", "firstName": "Ruslana", "lastName": "Tytarenko", "initials": "R", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Yaccoby S", "firstName": "Shmuel", "lastName": "Yaccoby", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Hillengass J", "firstName": "Jens", "lastName": "Hillengass", "initials": "J", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Roswell Park Comprehensive Cancer Center, Buffalo, NY."}}}, {"fullName": "Thanendrarajan S", "firstName": "Sharmilan", "lastName": "Thanendrarajan", "initials": "S", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Schinke C", "firstName": "Carolina", "lastName": "Schinke", "initials": "C", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "van Rhee F", "firstName": "Frits", "lastName": "van Rhee", "initials": "F", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Zangari M", "firstName": "Maurizio", "lastName": "Zangari", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Walker BA", "firstName": "Brian A", "lastName": "Walker", "initials": "BA", "authorId": {"@type": "ORCID", "#text": "0000-0002-8615-6254"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Barlogie B", "firstName": "Bart", "lastName": "Barlogie", "initials": "B", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Morgan GJ", "firstName": "Gareth J", "lastName": "Morgan", "initials": "GJ", "authorId": {"@type": "ORCID", "#text": "0000-0002-4271-6360"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Davies FE", "firstName": "Faith E", "lastName": "Davies", "initials": "FE", "authorId": {"@type": "ORCID", "#text": "0000-0002-3971-2393"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}, {"fullName": "Weinhold N", "firstName": "Niels", "lastName": "Weinhold", "initials": "N", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Myeloma Institute and."}}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0002-3971-2393"}, {"@type": "ORCID", "#text": "0000-0002-4271-6360"}, {"@type": "ORCID", "#text": "0000-0002-8615-6254"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "1", "volume": "132", "journalIssueId": "2703780", "dateOfPublication": "2018 Jul", "monthOfPublication": "7", "yearOfPublication": "2018", "printPublicationDate": "2018-07-01", "journal": {"title": "Blood", "ISOAbbreviation": "Blood", "medlineAbbreviation": "Blood", "NLMid": "7603509", "ISSN": "0006-4971", "ESSN": "1528-0020"}}, "pubYear": "2018", "pageInfo": "59-66", "abstractText": "Spatial intratumor heterogeneity is frequently seen in multiple myeloma (MM) and poses a significant challenge for risk classifiers, which rely on tumor samples from the iliac crest. Because biopsy-based assessment of multiple skeletal sites is difficult, alternative strategies for risk stratification are required. Recently, the size of focal lesions (FLs) was shown to be a surrogate marker for spatial heterogeneity, suggesting that data from medical imaging could be used to improve risk stratification approaches. Here, we investigated the prognostic value of FL size in 404 transplant-eligible, newly diagnosed MM patients. Using diffusion-weighted magnetic resonance imaging with background suppression, we identified the presence of multiple large FLs as a strong prognostic factor. Patients with at least 3 large FLs with a product of the perpendicular diameters >5 cm<sup>2</sup> were associated with poor progression-free survival (PFS) and overall survival (OS; median, 2.3 and 3.6 years, respectively). This pattern, seen in 13.8% of patients, was independent of the Revised International Staging System (RISS), gene expression profiling (GEP)-based risk score, gain(1q), or extramedullary disease (hazard ratio, 2.7 and 2.2 for PFS and OS in multivariate analysis, respectively). The number of FLs lost its negative impact on outcome after adjusting for FL size. In conclusion, the presence of at least 3 large FL is a feature of high risk, which can be used to refine the diagnosis of this type of disease behavior and as an entry criterion for risk-stratified trials.", "affiliation": "Myeloma Institute and.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print-Electronic", "pubTypeList": {"pubType": ["Clinical Trial", "Research Support, Non-U.S. Gov't", "research-article", "Multicenter Study", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": [{"grantId": "P01 CA055819", "agency": "NCI NIH HHS", "acronym": "CA", "orderIn": "0"}, {"grantId": "P20 GM125503", "agency": "NIGMS NIH HHS", "acronym": "GM", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Multiple Myeloma", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DG", "qualifierName": "diagnostic imaging", "majorTopic_YN": "Y"}, {"abbreviation": "MO", "qualifierName": "mortality", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "Y", "descriptorName": "Diffusion Magnetic Resonance Imaging"}, {"majorTopic_YN": "N", "descriptorName": "Disease-Free Survival"}, {"majorTopic_YN": "N", "descriptorName": "Survival Rate"}, {"majorTopic_YN": "N", "descriptorName": "Risk Assessment"}, {"majorTopic_YN": "N", "descriptorName": "Risk Factors"}, {"majorTopic_YN": "N", "descriptorName": "Adult"}, {"majorTopic_YN": "N", "descriptorName": "Middle Aged"}, {"majorTopic_YN": "N", "descriptorName": "Female"}, {"majorTopic_YN": "N", "descriptorName": "Male"}]}, "subsetList": {"subset": [{"code": "AIM", "name": "Core clinical journals"}, {"code": "IM", "name": "Index Medicus"}]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1182/blood-2018-04-842880"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6034645"}, {"availability": "Free", "availabilityCode": "F", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1182/blood-2018-04-842880"}]}, "isOpenAccess": "N", "inEPMC": "Y", "inPMC": "N", "hasPDF": "N", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "17", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-07-02", "dateOfCreation": "2018-05-23", "firstIndexDate": "2018-05-23", "fullTextReceivedDate": "2020-07-11", "dateOfRevision": "2021-02-02", "electronicPublicationDate": "2018-05-21", "firstPublicationDate": "2018-05-21", "embargoDate": "2019-07-05"}, "abstract": "Spatial intratumor heterogeneity is frequently seen in multiple myeloma (MM) and poses a significant challenge for risk classifiers, which rely on tumor samples from the iliac crest. Because biopsy-based assessment of multiple skeletal sites is difficult, alternative strategies for risk stratification are required. Recently, the size of focal lesions (FLs) was shown to be a surrogate marker for spatial heterogeneity, suggesting that data from medical imaging could be used to improve risk stratification approaches. Here, we investigated the prognostic value of FL size in 404 transplant-eligible, newly diagnosed MM patients. Using diffusion-weighted magnetic resonance imaging with background suppression, we identified the presence of multiple large FLs as a strong prognostic factor. Patients with at least 3 large FLs with a product of the perpendicular diameters >5 cm<sup>2</sup> were associated with poor progression-free survival (PFS) and overall survival (OS; median, 2.3 and 3.6 years, respectively). This pattern, seen in 13.8% of patients, was independent of the Revised International Staging System (RISS), gene expression profiling (GEP)-based risk score, gain(1q), or extramedullary disease (hazard ratio, 2.7 and 2.2 for PFS and OS in multivariate analysis, respectively). The number of FLs lost its negative impact on outcome after adjusting for FL size. In conclusion, the presence of at least 3 large FL is a feature of high risk, which can be used to refine the diagnosis of this type of disease behavior and as an entry criterion for risk-stratified trials.", "journaltitle": "Blood", "authorinfo": ["Rasche L", "Angtuaco EJ", "Alpe TL", "Gershner GH", "McDonald JE", "Samant RS", "Kumar M", "Van Hemert R", "Epstein J", "Deshpande S", "Tytarenko R", "Yaccoby S", "Hillengass J", "Thanendrarajan S", "Schinke C", "van Rhee F", "Zangari M", "Walker BA", "Barlogie B", "Morgan GJ", "Davies FE", "Weinhold N"], "title": "The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma."}